newsfilter
← Latest News
Business Wire·

Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results

Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported